Home > Insider Trading > Filing (0001181431-12-011545)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1400431	Patheon Inc	PTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226288	C James Mullen	4721 Emperor Blvd Suite 200 Durham NC 27703	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Restricted Voting Shares	Acquisiton	2012-02-22	6,000	$1.71	818,385	No	4	P	Direct
Restricted Voting Shares	Acquisiton	2012-02-23	19,000	$1.71	837,385	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 12, 2012.
These shares were purchased in a single transaction at a price of $1.71. The amounts reported in column 4 and this footnote (2) were converted from Canadian dollars into U.S. dollars based on the February 22, 2012 closing exchange rate of 0.9966 Canadian dollars per U.S. dollar as quoted by Reuters.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.73, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote (3). The amounts reported in column 4 and this footnote (3) were converted from Canadian dollars into U.S. dollars based on the February 23, 2012 closing exchange rate of 0.9974 Canadian dollars per U.S. dollar as quoted by Reuters.